Literature DB >> 21264951

Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome.

Shintaro Iwama1, Yoshihisa Sugimura, Haruyuki Suzuki, Hiromi Suzuki, Takashi Murase, Nobuaki Ozaki, Hiroshi Nagasaki, Hiroshi Arima, Yoshiharu Murata, Makoto Sawada, Yutaka Oiso.   

Abstract

Osmotic demyelination syndrome (ODS) is a serious demyelinating disease in the central nervous system usually caused by rapid correction of hyponatremia. In an animal model of ODS, we previously reported microglial accumulation expressing proinflammatory cytokines. Microglia and astrocytes secreting proinflammatory cytokines and neurotrophic factors are reported to be involved in the pathogenesis of demyelinative diseases. Therefore, to clarify the role of microglial and astrocytic function in ODS, we examined the time-dependent changes in distribution, morphology, proliferation, and mRNA/protein expression of proinflammatory cytokines, neurotrophic factors, and matrix metalloproteinase (MMP) in microglia and astrocytes 2 days (early phase) and 5 days (late phase) after the rapid correction of hyponatremia in ODS rats. The number of microglia time dependently increased at demyelinative lesion sites, proliferated, and expressed tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, inducible nitric oxide synthase, and MMP2, 9, and 12 at the early phase. Microglia also expressed leukemia inhibitory factor (a neurotrophic factor) and phagocytosed myelin debris at the late phase. The number of astrocytes time dependently increased around demyelinative lesions, extended processes to lesions, proliferated, and expressed nerve growth factor and glial cell line-derived neurotrophic factor at the late phase. Moreover, treatment with infliximab, a monoclonal antibody against TNF-α, significantly attenuated neurological impairments. Our results suggest that the role of microglia in ODS is time dependently shifted from detrimental to protective and that astrocytes play a protective role at the late phase. Modulation of excessive proinflammatory responses in microglia during the early phase after rapid correction may represent a therapeutic target for ODS.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21264951     DOI: 10.1002/glia.21114

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  16 in total

Review 1.  Neurological counterparts of hyponatremia: pathological mechanisms and clinical manifestations.

Authors:  Manuel Alfredo Podestà; Irene Faravelli; David Cucchiari; Francesco Reggiani; Silvia Oldani; Carlo Fedeli; Giorgio Graziani
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

2.  Astrocytes are an early target in osmotic demyelination syndrome.

Authors:  Fabrice Gankam Kengne; Charles Nicaise; Alain Soupart; Alain Boom; Johan Schiettecatte; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

3.  Asymptomatic central pontine myelinolysis without hyponatriemia in diffuse large B cell lymphoma.

Authors:  Elisa Doni; Lucio Tremolizzo; Mirko Patassini; Pietro Enrico Pioltelli; Carlo Ferrarese; Ildebrando Appollonio
Journal:  Neurol Sci       Date:  2016-08-03       Impact factor: 3.307

4.  Anti-pituitary antibodies against corticotrophs in IgG4-related hypophysitis.

Authors:  Naoko Iwata; Shintaro Iwama; Yoshihisa Sugimura; Yoshinori Yasuda; Kohtaro Nakashima; Seiji Takeuchi; Daisuke Hagiwara; Yoshihiro Ito; Hidetaka Suga; Motomitsu Goto; Ryoichi Banno; Patrizio Caturegli; Teruhiko Koike; Yoshiharu Oshida; Hiroshi Arima
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

5.  c-Jun and c-Fos regulate the complement factor H promoter in murine astrocytes.

Authors:  Laura A Fraczek; Carol B Martin; Brian K Martin
Journal:  Mol Immunol       Date:  2011-09-14       Impact factor: 4.407

6.  Osmotic Stress-Induced Defective Glial Proteostasis Contributes to Brain Demyelination after Hyponatremia Treatment.

Authors:  Fabrice Gankam-Kengne; Bruno S Couturier; Alain Soupart; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2017-01-25       Impact factor: 10.121

7.  Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis.

Authors:  Shintaro Iwama; Yoshihisa Sugimura; Atsushi Kiyota; Takuya Kato; Atsushi Enomoto; Haruyuki Suzuki; Naoko Iwata; Seiji Takeuchi; Kohtaro Nakashima; Hiroshi Takagi; Hisakazu Izumida; Hiroshi Ochiai; Haruki Fujisawa; Hidetaka Suga; Hiroshi Arima; Yoshie Shimoyama; Masahide Takahashi; Hiroshi Nishioka; San-e Ishikawa; Akira Shimatsu; Patrizio Caturegli; Yutaka Oiso
Journal:  J Clin Endocrinol Metab       Date:  2015-04-28       Impact factor: 5.958

Review 8.  Noninvasive molecular imaging of neuroinflammation.

Authors:  Andreas H Jacobs; Bertrand Tavitian
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-02       Impact factor: 6.200

9.  Functional diversity of microglia - how heterogeneous are they to begin with?

Authors:  Uwe-Karsten Hanisch
Journal:  Front Cell Neurosci       Date:  2013-05-14       Impact factor: 5.505

10.  Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?

Authors:  Cédric Rafat; Martin Flamant; Stéphane Gaudry; Emmanuelle Vidal-Petiot; Jean-Damien Ricard; Didier Dreyfuss
Journal:  Ann Intensive Care       Date:  2015-11-09       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.